UnknownEarly Phase 1NCT02077543

Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma

Studying Oligodendroglioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Grenoble
Principal Investigator
François BERGER, MD, PhD
University Grenoble Hospital
Intervention
Brain Tissue Imprint - Medical Device (ProTool)(device)
Enrollment
150 target
Eligibility
18-80 years · All sexes
Timeline
2013 – 2020

Study locations (5)

Collaborators

MEDIMPRINT · Institut National de la Santé Et de la Recherche Médicale, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02077543 on ClinicalTrials.gov

Other trials for Oligodendroglioma

Additional recruiting or active studies for the same condition.

See all trials for Oligodendroglioma →

← Back to all trials